Ovation Pharmaceuticals Overview

Life ScienceCompany

Was Ovation Pharmaceuticals formerly PE-backed?

Yes. Ovation Pharmaceuticals was formerly owned by 1 private investor.

Where is Ovation Pharmaceuticals headquartered?

Ovation Pharmaceuticals is headquartered in Deerfield, Illinois.

What sector is Ovation Pharmaceuticals in?

Ovation Pharmaceuticals is a life science company.

When was Ovation Pharmaceuticals founded?

Ovation Pharmaceuticals was founded in 2000.

Ovation Pharmaceuticals, Inc.

Deerfield, Illinois
United States,
www.ovationpharma.com

Ovation Pharmaceuticals is a specialty pharmaceutical company focused on acquiring underpromoted branded pharmaceutical products and promising late-stage development products. Ovation increases the sales of its acquired products through the implementation of active selling efforts, creative marketing programs, and through product life cycle activities that are focused on developing new formulations, new indications, and other product improvements. Ovation is led by CEO Jeff Aronin and Executive Chairman Bill Gantz.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.